Clicky

Jinxin Fertility Group Ltd(JXFGF)

Description: Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.


Keywords: Investment Management Real Estate Development Human Reproduction Treatment Solutions Fertility Reproduction Sexual Reproduction Fertility Medicine In Vitro Fertilisation Assisted Reproductive Technology Semen Cryobiology Sperm Donation Artificial Insemination Assisted Reproductive Services Intracytoplasmic Sperm Injection Ambulatory Surgery Center Facilities Services Ancillary Medical Services Ivf Technology Pre Implantation Genetic Screening Testing Services

Home Page: www.jxr-fertility.com

No. 301, North Jingsha Road
Chengdu,
China
Phone: 86 28 6769 5992


Officers

Name Title
Mr. Yong Zhong Executive Chairman of the Board
Mr. Yang Dong CEO & Executive Director
Ms. Rong Lyu Co-CEO & Executive Director
Dr. John G. Wilcox FACOG, M.D. Executive Director
Dr. Lihong Geng Executive Director
Ms. Hanmei Huang Chief Financial Officer
Ms. Hongmei Duan Chief Operating Officer
Dr. Yuan Li Chief Medical Officer
Ms. Yangyang Zhai Joint Company Secretary
Ms. Sau Mei Ng ACIS, ACS, FCIS, FCS Joint Company Secretary

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 7.2359
Trailing PE: 24.5
Price-to-Book MRQ: 0.9601
Price-to-Sales TTM: 0.464
IPO Date:
Fiscal Year End: December
Full Time Employees: 3779
Back to stocks